Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 5-10 , 15 May 2010

New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence

Received 22 October 2009 ,Revised 24 January 2010 ,Accepted 2 February 2010.

References 

  1. Hafler DA. Multiple sclerosis. J Clin Invest. Mar 2004;113(6):788–794
  2. Prat A, Antel J. Pathogenesis of multiple sclerosis. Curr Opin Neurol. 2005 Jun;18(3):225–230
  3. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005 Dec;58(6):840–846
  4. Glynn P, Linington C. Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system. Crit Rev Neurobiol. 1989;4(4):367–385
  5. Klehmet J. T cell epitope spreading in myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis. Clin Immunol. 2004 Apr;111(1):53–60
  6. Steinman L. Escape from “horror autotoxicus:” pathogenesis and treatment of autoimmune disease. Cell. 1995 Jan 13;80(1):7–10
  7. Bar-Or A, Oliveira EM, Anderson DE, Hafler DA. Molecular pathogenesis of multiple sclerosis. J Neuroimmunol. 1999 Dec;100(1–2):252–259
  8. Marie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004 Dec;3(12):709–718
  9. Kurtzke JF. Geography in multiple sclerosis. J Neurol. 1977 Apr 28;215(1):1–26
  10. Islam T, Gauderman WJ, Cozen W, Mack TM. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology. July 24, 2007;69:381–388
  11. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand. 1960;35(suppl 147):132–147
  12. Davis GE, Lowell WE. Solar cycles and their relationship to human disease and adaptability. Med Hypotheses. 2006;67(3):447–461Electronic publication 2006 May15
  13. van der Mei IA, Ponsonby AL, Dwyer T, et al. Past sun exposure to sun, skin phenotype, and risk of multiple sclerosis: case–control study. BMJ. 2003;327:316
  14. Schwartz T. Mechanisms of UV-induced immunosuppression. Keio J Med. 2005 Dec;54(4):165–171
  15. Goettsch W, Garssen J, de Gruijl FR, van Loveren H. UV-B and the immune system: a review with special emphasis on T cell-mediated immunity. Thymus. 1993;21:93–114
  16. Kripke ML. Ultraviolet radiation and immunology: something new under the sun—presidential address. Cancer Res. 1994;54:6102–6105
  17. Sleijffers A, Garssen J, Van Loveren H. Ultraviolet radiation, resistance to infectious diseases, and vaccination responses. Methods. 2002;28:111–121
  18. Shreedhar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol. 1998;160:3783–3789
  19. Shreedhar VK, Pride MW, Sun Y, Kripke ML, Strickland FM. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol. 1998;161:1327–1335
  20. Hutter CD, Laing P. Multiple sclerosis: sunlight, diet, immunology and aetiology. Med Hypotheses. 1996 Feb;46(2):67–74
  21. Ponsonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology. 2002 Dec 27;181–182:71–78
  22. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium, and vitamin D. Med Hypotheses. 1986 Oct;21(2):193–200
  23. Freedman DM, Dosemeci M, Alavanja MCR. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case–control study based on death certificates. Occup Environ Med. 2000;57:418–421
  24. Cantorna MT, Hayes CE, Deluca HF. 1, 25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861–7864
  25. Hayes CE, Cantorna , DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med. 1997 Oct;216(1):21–27
  26. Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC. A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis. J Neurol Neruosurg Psychiatry. 2005 Sep;76(9):1294–1296
  27. Steinman L, Zamvil SS. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 2005 Nov;26(11):565–571Electronic publication 2005 Sep 8
  28. Friese MA, Montalban X, Willcox N, Bell JI, Martin R, Fugger L. The value of animal models for drug development in multiple sclerosis. Brain. 2006 Aug;129(Pt 8):1940–1952Electronic publication 2006 Apr 24
  29. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004 Jan 13;62(1):60–65
  30. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20;296(23):2832–2838
  31. Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypothesis. 2005;64(3):608–618
  32. Tajouri L, Ovcaric M, Curtain R, Johnson MP, Griffiths LR, Csurhes P, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet. 2005 Jan-Mar;19(1):25–38
  33. Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci. 1999 Jun 15;166(1):47–52
  34. Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, Thomson RJ, et al. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler. 2009 May;15(5):563–570
  35. Smolders J, Peelen E, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009 Jun;8(7):621–626
  36. Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Annal N Y Acad Sci. 2009 Sep;1173:515–520
  37. Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler. 2005 Jun;11(3):266–271
  38. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009 May;132(Pt 5):1146–1160
  39. van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007 May;254(5):581–590Electronic publication 2007 Apr 11
  40. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Gen. 2009 Feb;5(2):e1000369
  41. Garcion E, Sindji L, Nataf S, Brachet P, Darcy F, Montero-Menei CN. Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol. 2003 May;105(5):438–448Electronic publication 2003 Jan 31
  42. Cantorna MT, Hayes CE, DeLuca HF. 1, 25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861–7864
  43. Lemire JM, Archer DC. 1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991 Mar;87(3):1103–1107
  44. Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC. A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1294–1296
  45. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008 Nov;14(9):1220–1224Electronic publication 2008 Jul 24
  46. Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152–157[Electronic publication 2007 Jun 19]. doi:10.1007/s00774-005-0604-9.
  47. Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005;23(4):309–313
  48. Neumann H. Control of glial immune function by neurons. Glia. 2001 Nov;36(2):191–199
  49. Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science. July 28, 1995;269:
  50. Corriveau RA, Huh GS, Shatz CJ. Neuron. Sept 1998;21:505–520
  51. Neumann H, Boucraut J, Hahnel C, Misgeld T, Wekerle H. Neuronal control of MHC II inducibility in rat astrocytes and microglia. Eur J Neurosci. 1996 Dec;8(12):2582–2590
  52. Barlow RB, Snodderly DM, Swadlow HA. Intensity coding in primate visual system. Exp Brain Res. 1978 Feb 15;31(2):163–177
  53. Barlow RB, Verrillo RT. Brightness sensation in a ganzfeld. Vision Res. 1976;16(11):1291–1297
  54. Carson M. Microglia as a liaison between immune and central nervous systems: functional implications for multiple sclerosis. Glia. 2002 Nov;40(2):218–231
  55. Abbas AK, Lichtman AH. Basic immunology: functions and disorders of the immune system, second edition. Philadelphia, PA: Saunders, 80-2.
  56. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87–113
  57. Goodin DS, Cohen BA, O'Connor P, Kappos L, Stevens JC. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 Sep 2;71(10):766–773
  58. Aranami T, Yamamura T. Th17 cells and autoimmune encephalophalomyelitis (EAE/MS). Allerol Int. 2008;57:115–120
  59. Sandyk R, Awerbuch GI. The pineal gland in multiple sclerosis. Int J Neurosci. 1991 Nov;61(1–2):61–67
  60. Benarroch EE. Suprachiasmatic nucleus and melatonin, reciprocal interactions and clinical correlations. Neurology. 2008 August 19;71:594–598
  61. Kaur C, Ling EA. Effects of melatonin on macrophages/microglia in postnatal rat brain. J Pineal Res. 1999 Apr;26(3):158–168
  62. Pang W, Li C, Zhao Y, Wang S, Dong W, Jiang P, et al. The environmental light influences the circulatory levels of retinoic acid and associates with hepatic lipid metabolism. Endocrinology. 2008 Dec;149(12):6336–6342
  63. McCaffery P, Mey J, Drager UC. Light-mediated retinoic acid production. Proc Nat Acad Sci. 1996 Oct 29;93(22):12570–12574
  64. Hutter C. On the causes of multiple sclerosis. Med Hypotheses. 1993 Aug;41(2):93–96
  65. Brass SD, Zivadinov R, Bakshi R. Acute demyelinating optic neuritis: a review. Front Biosci. 2008 Jan 1;13:2376–2390
  66. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, et al. Antibody to aquaporin 4 in diagnosis of neuromyelitis optica. PLoS Med. 2007 Apr;4(4):e133
  67. Mahmoud I, Salman SS, Al-Khateeb A. Continuous darkness and continuous light induce structural changes in the rat thymus. J Anat. 1994;3:107–117
  68. Brown SJ. The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006 Jun;40(6):1158–1161Electronic publication 2006 May 9
  69. Cavaletti G. Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. Neurol Sci. 2006 Apr;27(1):24–32

PII: S0022-510X(10)00061-4

doi: 10.1016/j.jns.2010.02.004

Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 5-10 , 15 May 2010

Article Tools

* Image Usage & Resolution